Related Experiment Video
Updated: Feb 20, 2026
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models
Alexander Morrison-Nozik1, Saptarsi M Haldar2,3
1Ohio University Heritage College of Osteopathic Medicine at Cleveland Clinic, Cleveland, OH, USA.
Abstract:
Investigations using mouse models have provided seminal insights into the pathogenesis of Duchenne muscular dystrophy and the development of novel therapeutics. Several important methods have been considered standard-in-the-field for analyses of skeletal muscle weakness, strength, endurance, and histopathology, as well as responses to therapeutics such as glucocorticoids, disease modifying drugs which are part of the current standard of care for patients with this disease. Here we describe optimized genetic, genomic, and physiologic assays to probe dystrophic pathobiology in the mdx mouse and related strains.
Insights
This study optimizes genetic, genomic, and physiologic assays in mdx mouse models to better understand Duchenne muscular dystrophy (DMD) and advance therapeutic development for this rare genetic disease.
Area of Science:
- Biomedical research
- Genetics
- Animal models
Background:
- Mouse models are crucial for understanding Duchenne muscular dystrophy (DMD) pathogenesis.
- Established methods exist for assessing muscle function and pathology in DMD mouse models.
- Glucocorticoids are standard care but novel therapeutics are needed.
Purpose of the Study:
- To describe optimized genetic, genomic, and physiologic assays.
- To probe dystrophic pathobiology in mdx mouse models and related strains.
- To improve the study of Duchenne muscular dystrophy.
Main Methods:
- Genetic assays
- Genomic assays
- Physiologic assays
- Utilized mdx mouse models and related strains.
Main Results:
- Optimized assays provide enhanced insights into dystrophic pathobiology.
- Improved methods for analyzing skeletal muscle weakness, strength, and endurance.
- Enhanced assessment of therapeutic responses in mouse models.
Conclusions:
- Optimized assays facilitate deeper understanding of DMD.
- These methods support the development of novel Duchenne muscular dystrophy therapeutics.
- Refined assays advance research in skeletal muscle disease and genetic disorders.
More Related Videos
14:10Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Related Concept Videos
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:21Satellite Stem Cells and Muscular Dystrophy